Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aimee M Dassner"'
Publikováno v:
Pediatric Infectious Disease Journal. 40:e507-e509
There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-1
Autor:
Aimee M. Dassner, Lee Morris, Rupal Patel, Jeanne B. Forrester, Stephanie N Welch, Nigel Rozario
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:1304-1311
Publikováno v:
Current Pediatric Reviews. 13:49-66
Background Pediatric pneumonia is one of the most common causes of childhood infection requiring hospitalization and is a substantial driver of antimicrobial use among hospitalized children. About 12-20% of pediatric patients hospitalized with commun
Autor:
Aimee M. Dassner, Jennifer E Girotto
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 7:113-118
Background A second-sign prospective restriction of select broad-spectrum antimicrobials was fully implemented in January 2015 as a pediatric antimicrobial stewardship program (ASP) initiative to help ensure the most appropriate empiric use of ceftar
Autor:
Jennifer E Girotto, Aimee M. Dassner, Romney M. Humphries, Jeanne B. Forrester, Lindsey Nielsen
Publikováno v:
J Clin Microbiol
The Clinical and Laboratory Standards Institute antimicrobial and antifungal standards define a susceptible-dose-dependent (SDD) category for certain organisms and drug combinations. Reporting MICs within the SDD category suggests that treatment succ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01801702964c7465f966d8f66eebec0
https://europepmc.org/articles/PMC6935900/
https://europepmc.org/articles/PMC6935900/
Publikováno v:
Open Forum Infectious Diseases
Background Bacteremia is a major cause of morbidity and mortality among children with acute myelogenous leukemia (AML) and chemotherapy-induced neutropenia. Data evaluating the utility of bacterial prophylaxis in this pediatric population are limited
Autor:
Rupal Patel, Nigel Rozario, Stephanie N Welch, Aimee M. Dassner, Lee Morris, Jeanne Forrester
Publikováno v:
Open Forum Infectious Diseases
Background Rapid diagnostic testing (RDT) in combination with antimicrobial stewardship programs (ASPs) has been associated with improved outcomes in adults with Staphylococcus aureus bacteremia (SAB). Data in children are lacking. In January 2017, A
Publikováno v:
Infectious Diseases and Therapy
Introduction Gram-negative multi-drug resistance is an emerging threat among pediatric patients with cystic fibrosis (CF). Ceftolozane/tazobactam (C/T) is an extended-spectrum cephalosporin/beta-lactamase inhibitor combination that has been shown to